Sell-side research aligns Salesforce stock forecast 2025 with a price target range of $330–$360, reflecting steady pipeline expansion and partner ecosystem growth. Since it has a market capitalisation of US$455m, AngioDynamics' US$18m in cash burn equates to about 3.9% of its market value. That's a low proportion, so we figure the company would be able to raise more cash to fund growth, with a little dilution, or even to simply borrow some money. If you are wondering whether Salesforce NYSE: CRM can hit new highs this year, it can, at least according to what the analysts are saying. Their activity capped gains following the FQ1 release but has set this market up to rebound strongly, if not following the FQ2 release, then by the end of the fiscal year. Salesforce stock forecast 2025 anticipates continued shareholder returns via buybacks, enhancing EPS and price multiples despite competitive pressures from Microsoft Dynamics